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Copyright © 2008 JCBN Summary The aim of this study was to examine whether malondialdehyde (MDA) formation,
a marker of oxidant stress, is altered in different stages of development of hyperlipidemia and
whether it correlates with atherogenic index (AI), an important risk factor of atherosclerosis.
Commercial kits were used to measure the levels of lipid profile and antioxidant status in the
serum of 15 hyperlipidemic patients and 30 age and sex-matched normolipidemic subjects.
The normolipidemic subjects were divided into lower and higher lipid groups according to
their blood lipid level. The activities of superoxide dismutase and glutathione peroxidase
decreased in higher lipid group compared with lower lipid group, and were even lower in
hyperlipidemic subjects. An increase in the levels of MDA, triglycerides, total cholesterol and
LDL-C concentration were observed in higher lipid group, and even significantly increased in
hyperlipidemic patients. A significant progressive decline in HDL-C concentration was found
during hyperlipidemia evolution. There was a positive correlation between MDA and AI
(r = 0.61, p<0.05). These data indicate that oxidative stress is an early event in the evolution of
hyperlipidemia, and appropriate support for enhancing antioxidant supply in higher lipid
subjects may help prevent the course of the disease.
Key Words:oxidative stress, hyperlipidemia, atherogenic index, antioxidant status, human
Introduction
Atherosclerosis, the underlying cause of heart attack,
stroke, and peripheral vascular disease, is a main cause of
morbidity and mortality worldwide. The disease can
generally be viewed as a form of chronic inflammation that
is induced and perturbed by lipid accumulation [1]. Hyper-
cholesterolemia and hypertriglyceridemia are independent
risk factors that alone or together can accelerate the develop-
ment of atherosclerosis and progression of atherosclerotic
lesions [2]. One of the initial events in the development
of atherosclerosis is the accumulation of cells containing
excess lipids within the arterial wall. In addition, it has been
demonstrated that increased intracellular generation of
reactive oxygen species (ROS) plays an important role in
chronic inflammatory responses to atherosclerosis [3].
ROS are generated in aerobic organisms during physio-
logical or physiopathological oxidative metabolism of
mitochondria. ROS may react with a variety of bio-
molecules, including lipids, carbohydrates, proteins, nucleic
acids, and macromolecules of connective tissue, there by
interfering with cell function. Under normal physiological
conditions, there is a critical balance in the generation of
oxygen free radicals and antioxidant defense systems.
Impairment in the oxidant/antioxidant equilibrium provokes
a situation of oxidative stress and generally results from
hyperproduction of ROS. Oxidative stress is known to be
a component of molecular and cellular tissue damage
mechanisms in a wide spectrum of human diseases [4]. A lotOxidative Stress in Progressive Hyperlipidemia
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of oxygenated compounds, particularly aldehydes such as
malondialdehyde (MDA) and conjugated dienes, are
produced during the attack of free radicals to membrane
lipoproteins and polyunsaturated fatty acids. Enzymic
superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px) and nonenzymic antioxidants play an important
role in alleviating tissue damage due to the formation of
free radicals. A lot of studies have found that serum MDA
are higher in subjects with hyperlipidemia and decrease
following dietary supplementation with antioxidants. Similar
observations have been reported in animal models of
hyperlipidemia [5, 6].
Though data is available on lipid profile, oxidant/anti-
oxidant status in hyperlipidemic patients but no comparison
about different blood lipid level stages has been made. The
aims of the present study were, 1) to determine whether
oxidative damage occurs, and to what degree, at different
stages in the development of hyperlipidemia and, 2) to
assess the oxidant/antioxidant balance in the three group
subjects. To this end, indicative parameters of lipid per-
oxidation, together with some enzymatic antioxidant system
activities, such as SOD and GSH-Px were evaluated. To our
knowledge, this study is the first to examine the relation
between oxidative stress and the disturbance of lipid profile
in human with varying levels of blood lipid level, repre-
senting different stages in the development of hyperlipi-
demia.
Materials and Methods
Subjects
Recruitment of subjects for this study was carried out at
the Jiangnan University hospital. The subjects participating
in this study visited the hospital for health survey and
underwent a clinical examination. We selected 45 subjects
for our study based on the following lipid level: normolipi-
demics total cholesterol <5.2 mmol/L and triglycerides
<1.5 mmol/L; hyperlipidemics (group III) total cholesterol
>4.5 mmol/L, triglycerides >1.7 mmol/L. The normolipi-
demic subjects were divided into two groups according their
blood lipid level: the lower lipid group (group I) and the
higher lipid group (group II). All subjects have almost
similar economic status, food habits, and physical activity.
Lactating mother, cigarette smokers and alcoholics were
excluded from the study. Hyperlipidemia with other compli-
cations like hypertension, uncontrolled diabetes mellitus and
pregnant women were also excluded from the study. None of
the subjects were taking antioxidant vitamin supplements,
lipid-lowering drugs. Written consent was obtained from all
individuals after the purpose and nature of the study had
been explained. The ethical committee of Jiangnan Univer-
sity approved the study protocol. Participants were invited
to attend the hospital after an overnight fast. Following
registration, fasting blood samples were collected from all
the subjects. Serum was obtained from blood samples after
centrifugation (1000 g for 10 min at 4°C) and the lipid
parameters were determined from fresh sera. Sera for
antioxidant enzymes activity measurements were kept at
−20°C before analysis.
Biochemical analysis
For determination of plasma total cholesterol (TC), low
density lipoprotein-cholesterol (LDL-C), high density
lipoprotein-cholesterol (HDL-C) and triglycerides concen-
trations, the corresponding diagnostic kits (Nanjing
Jiancheng Bioengineering Institute, Nanjing, PR China)
were used according to the instructions of the manufacturer.
The atherosclerotic index (AI) was calculated as (TC-HDL-
C)/HDL-C. Plasma thiobarbituric acid reactive substances
(TBARS) [7], plasma SOD [8], GSH-Px [9] and total anti-
oxidant capacity (TAC) [10] were also assayed.
Statistical analysis
Data were expressed as the means and standard deviations
(S.D.). Comparisons across groups were performed by a
one-way analysis of variance (ANOVA) followed by
Tukey’s honestly significant difference post hoc test and
Student’s t test. Differences with p<0.05 were considered
statistically significant. Correlation coefficients were deter-
mined by Pearson’s correlation test. Analysis was done with
SPSS 11.5 (SPSS, Inc., Chicago, IL).
Results
Subjects’ details and lipid profile are shown in Table 1.
The levels of TG, TC and LDL-C were significantly higher
than those in group I subjects, both in group II and group III
subjects. LDL-C level in the group II subjects was even
higher than group III subjects but no significant difference
between them. HDL-C level was significantly lower in the
group II subjects and even lower in the group III subjects
compared with the levels of the age and sex-matched group
I subjects, as shown in Table 1.
Table 1 represents the levels of TBARS, TAC, and the
activities of SOD and GSH-Px in normal and hyperlipidemic
subjects. MDA levels (13.89 ± 3.80 nmol/ml) had already
increased in group II subjects and rose even further signifi-
cantly in the group III subjects (26.12 ± 5.93 nmol/ml)
compared with that in group I subjects (10.53 ± 2.50 nmol/
ml, p<0.05). TAC was not significantly different among the
three groups. The activities of SOD significantly decreased
in group II and more pronounced in hyperlipidemic patients
compared with that in group I subjects. The lowest GSH-Px
activity was found in group III subjects. In group II subjects,
GSH-Px activity was also significantly lower than in group I
subjects.R.-L. Yang et al.
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As detailed in Fig. 1, Values of AI were also increased
in group III subjects compared with group I or group II
subjects. The latter group also showed higher AI than the
former group.
Fig. 2 shows the correlations between AI and MDA
levels in all subjects. The significant positive correlation
between serum MDA levels and AI was observed (r =0 . 6 1 ,
p<0.05). Thus, the atherogenic index was high in groups
with an increased lipid peroxidation level.
Discussion
This study demonstrated that the elevated concentrations
of MDA, an end product of polyunsaturated fatty acid
peroxidation, had present in higher lipid group. This
suggests that ROS may already have exerted their cytotoxic
effects in this early clinical stage of the disease. To our
knowledge, no studies regarding oxidative/antioxidative
status at different stages of hyperlipidemia, which repre-
sented by varying levels of blood lipid level, have been
previously published. Furthermore, MDA levels continued
to rise over the course of the disease, indicating over-
production of free radicals and leading to lipid peroxidation
and cell oxidative injury, which is considered by some
authors to be related to the development of hyperlipidemia
complications [11]. Our results demonstrate that enhanced
lipid peroxidation and decreased antioxidant enzyme
activity represent early events in the development of hyper-
lipidemia in human.
Further hypertriglyceridemia and hypercholesterolemia
were associated with oxidative modification of LDL, protein
glycation, glucose-autooxidation, thus leading to excess
production of lipid peroxidation products which may cause
elevation of oxidative stress in higher lipid and hyper-
lipidemic subjects. Interestingly, we observed that LDL-C
level in higher lipid subjects was even higher than hyper-
lipidemic subjects. Clinical and epidemiological studies
have proven that individuals with elevated LDL show an
increased risk for cardiovascular diseases [12]. HDL may be
protective by reversing cholesterol transport, inhibiting the
oxidation of LDL and by neutralizing the atherogenic effects
of oxidized LDL [13]. Decreased HDL and increased LDL
in higher lipid group may contribute to the disease develop-
ment.
Increased lipid peroxidation thought to be a consequence
Table 1. Age, BMI, blood lipid level and antioxidant status in lower lipid, higher lipid and hyperlipidemic groups
Values are expressed as mean ± SD for 15 subjects. Values in the same line with different superscripts are significantly
different at p<0.05 level, as assessed by a one-way analysis of variance. BMI indicates body mass index; LDL, low-density
lipoprotein; HDL, high-density lipoprotein.
Variable
normolipidemic subjects (n = 30) hyperlipidemic subjects (n = 15)
Group I (lower) Group II (higher) Group III
n1 5 1 5 1 5
Sex (male/female) 9/6 9/6 10/5
Age, years 49.75 ± 10.15 51.35 ±  11.20 52.23 ± 11.80
BMI, kg/m2 21.82 ± 2.71 22.95 ± 2.45 24.95 ± 3.12
Total cholesterol (mmol/L) 4.04 ± 0.69a 4.83 ± 0.87b 5.05 ± 0.91b
Triglycerides (mmol/L) 0.48 ± 0.14a 1.24 ± 0.04b 3.20 ± 1.19c
HDL-C (mmol/L) 1.45 ± 0.16a 1.21 ± 0.12b 1.05 ± 0.10c
LDL-C (mmol/L) 1.90 ± 0.57a 3.09 ± 0.89b 2.82 ± 0.94b
TAC (U/ml) 11.54 ± 1.56a 12.63 ± 1.29a 12.29 ± 1.67a
SOD (U/ml) 110.18 ± 18.82a 92.05 ± 20.35b 90.15 ± 22.35b
GSH-PX (U/ml) 220.92 ± 37.80a 185 ± 30.7b 172.54 ± 32.23c
MDA (nmol/ml) 10.53 ± 2.50a 13.89 ± 3.80a 26.12 ± 5.93b
Fig. 1. The atherogenic index of lower lipid, higher lipid and
hyperlipidemic groups. Values are expressed as mean ±
SD for 15 subjects. Values with different superscripts
are significantly different at p<0.05 level, as assessed by
a one-way analysis of variance. AI indicates atherogenic
index.Oxidative Stress in Progressive Hyperlipidemia
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of oxidative stress which occurs when the dynamic balance
between prooxidant and antioxidant mechanism is impaired
[14]. It is known that hyperlipidemic states are associated
with altered physical properties of cellular membranes [15],
which may facilitate the escape of free radicals from the
mitochondrial electron transport chain or the activation of
NADPH oxidase [16]. In agreement with this hypothesis,
studies in hypercholesterolemic rabbits have shown that
oxidative stress may be reduced by lipid lowering based on
dietary intervention in the absence of drugs [17]. Our study
found that circulating concentrations of MDA in the higher
lipid and hyperlipidemic groups were 1.33-fold, 2.48-fold
higher, respectively, compared to the lower lipid group,
indicating increasing oxidative stress with progressive
hyperlipidemia. These increased levels could be attributed to
increased ROS production and/or deficiency of antioxidant
defense system. We have observed decreased activities of
SOD and GSH-Px in higher lipid subjects. SOD and GSH-
Px are the first line of cellular defense against oxidative
injury which is involved in the disposal of superoxide anions
and hydrogen peroxide. Thus, insufficient detoxification of
these reactive oxygen species by antioxidant enzymes may
lead to an occurrence of imbalance between antioxidant and
oxidant systems. Low SOD and GSH-Px activity could also
attribute to enzyme inactivation by ROS bringing about
damage to proteins. In vitro studies have shown that
although GSH-Px is a relatively stable enzyme, it may be
inactivated under conditions of severe oxidative stress [18].
Our results demonstrated that TAC was not significantly
different among the three groups, results that did not agree
with those of Zhang S et al. [19], who reported decreased
TAC in a group of hyperlipidemia. One possible explanation
was that absolute concentrations of lipid-soluble vitamins
such as α-tocopherol and β-carotene correlate with lipids
and hyperlipidemia is commonly associated with increased
levels of these vitamins. However, their concentrations may
be lower than control levels if adjusted for total lipids
(cholesterol plus triglycerides) [20].
These alterations in the levels of serum lipid peroxide and
antioxidant status in subjects with higher serum TC, LDL-C,
and lower HDL-C levels may increase the susceptibility of
LDL to oxidation in the circulation. As a lipid peroxidation
process leading to increased atherogenity of LDL, it follows
that antioxidant status should have a major impact not only
on the rate of LDL oxidation but perhaps on development of
atherosclerosis [21]. It is possible that a potential risk of
atherosclerosis in higher lipid group was associated with
LDL oxidation as a result of increased levels of LDL-C and
decreased antioxidant enzyme activity.
In summary, our results showed that an imbalance in the
oxidant/antioxidant ratio is already present at higher lipid
subjects. The findings of the present study suggest a
therapeutic role for antioxidants in protecting from oxidative
damage by ROS in the higher lipid period of the disease.
Thus, in subjects with high risk for developing hyper-
lipidemia, treatment with antioxidants might reduce the
peroxidation rate, restore the body’s antioxidant capacity,
and possibly prevent or delay development of this disease.
This study is a relatively small number of subjects in groups.
Further studies with a more extensive group of subjects need
to be performed to examine these results.
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